Empowered Funds’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$731K Sell
9,256
-28,717
-76% -$2.44M ﹤0.01% 1550
2026
Q1
$3.27M Buy
+37,973
New +$3.41M 0.02% 842
2025
Q4
Sell
-4,367
Closed -$250K 1353
2025
Q3
$250K Buy
4,367
+75
+2% +$4.32K ﹤0.01% 1653
2025
Q2
$253K Sell
4,292
-81,435
-95% -$5.26M ﹤0.01% 1575
2025
Q1
$6.28M Buy
85,727
+8,295
+11% +$685K 0.09% 310
2024
Q4
$6.4M Buy
+77,432
New +$6.11M 0.09% 300
2023
Q1
Sell
-7,852
Closed -$583K 595
2022
Q4
$583K Buy
+7,852
New +$535K 0.04% 343
2019
Q1
Sell
-24,234
Closed -$1.05M 102
2018
Q4
$1.05M Sell
24,234
-7,621
-24% -$380K 0.44% 88
2018
Q3
$1.79M Buy
+31,855
New +$1.68M 0.53% 61

Other funds holding GMED

Empowered Funds's GMED Position: Q2 2026 in Review

Empowered Funds reduced its Globus Medical (GMED) stake by 76% in Q2 2026, selling an estimated $2.44M and leaving 9,256 shares worth $731K. The position accounts for ﹤0.01% of the portfolio, ranked #1550.

Empowered Funds first reported a position in GMED in Q3 2018 and has held it in 9 quarters since. The position peaked at $6.4M in Q4 2024. 596 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Empowered Funds held 9,256 shares of Globus Medical worth $731K as of Q2 2026.
  • Empowered Funds sold 28,717 Globus Medical shares in Q2 2026, an estimated $2.44M.
  • Globus Medical made up ﹤0.01% of Empowered Funds's portfolio in Q2 2026, its #1550 holding.
  • Empowered Funds first reported a position in Globus Medical in Q3 2018 and has held it in 9 quarters since.
  • Empowered Funds's Globus Medical position peaked at $6.4M in Q4 2024.
  • 596 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Empowered Funds's 13F filing for Q2 2026, filed 17 Aug 2026.